COO
The Cooper Companies, Inc
NASDAQ: COO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$60.00
-1.82% today
Updated 2026-05-08
Market cap
$11.92B
P/E ratio
30.40
P/S ratio
2.87x
EPS (TTM)
$2.01
Dividend yield
—
52W range
$60 – $90
Volume
2.2M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B7.0
Quality
B+6.0
Profitability
B6.0
Valuation
B4/9
Piotroski F-Score
Moderate
2.7
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$91.07
+51.78%
12-Month target
$60.46
+0.77%
Intrinsic (DCF)
$221.31
Margin of safety
+62.47%
5 Strong Buy6 Buy6 Hold1 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $158.70M — positive
+ 62.47% below intrinsic value
+ Debt/equity 0.34x — low leverage
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.59B | $3.90B | $4.09B | $4.15B |
| Net income | $385.80M | $294.20M | $392.30M | $374.90M | $130.80M |
| EPS | — | — | — | — | $2.01 |
| Free cash flow | $450.40M | $215.00M | $288.10M | $433.70M | $158.70M |
| Profit margin | 11.66% | 8.19% | 10.07% | 9.16% | 9.67% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | WEISS, ROBERT S | Buy | 3,779 | — |
| 2026-04-01 | WEISS, ROBERT S | Sale | 3,654 | — |
| 2026-04-01 | WEISS, ROBERT S | Buy | 3,654 | — |
Peer comparison
Smart narrative
The Cooper Companies, Inc trades at $60.00. representing a P/E of 30.40x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.65, it sits in the grey zone. TTM revenue stands at $4.15B. with profit margins at 9.67%. Our DCF model estimates intrinsic value at $221.31.
Frequently asked questions
What is The Cooper Companies, Inc's stock price?
The Cooper Companies, Inc (COO) trades at $60.00.
Is The Cooper Companies, Inc overvalued?
Smart Value Score 63/100 (Grade C+, Hold). DCF value $221.31.
What is the price target of The Cooper Companies, Inc (COO)?
The analyst target price is $91.07, representing +51.8% upside from the current price of $60.00.
What is the intrinsic value of The Cooper Companies, Inc (COO)?
Based on our DCF model, intrinsic value is $221.31, a +62.5% margin of safety versus $60.00.
What is The Cooper Companies, Inc's revenue?
TTM revenue is $4.15B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.65 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.87x
ROE4.87%
Beta0.89
50D MA$70.59
200D MA$73.95
Shares out0.20B
Float0.19B
Short ratio—
Avg volume2.2M
Performance
1 week-3.78%
1 month-15.74%
3 months-26.92%
YTD-26.79%
1 year—
3 years—
5 years—